Global Oncolytic Virus Therapy Market Projected to Expand at 23.7% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Oncolytic Virus Therapy Market Size Likely To Evolve From 2025 Through 2034?

The oncolytic virus therapy market size has experienced significant expansion in recent years. This market is projected to expand from $0.19 billion in 2024 to $0.23 billion in 2025, showing a compound annual growth rate (CAGR) of 25.0%. The growth observed historically can be attributed to several factors including improved genetic engineering techniques, a heightened understanding of the tumor microenvironment, successful clinical outcomes and regulatory greenlights, the increasing prominence of immunotherapy in cancer treatment, and innovations in gene delivery systems.

The oncolytic virus therapy market size is anticipated to undergo significant expansion in the next few years. It is projected to reach $0.55 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 23.7%. The expected rise during this forecast period can be attributed to several factors, including the proliferation of oncolytic virus platforms, the use of combination therapies with immune checkpoint inhibitors, personalized medicine approaches, the broadening of the clinical trial landscape, and supportive regulatory guidelines. Key trends anticipated in the forecast period encompass technological advances in delivery systems, advancements in synthetic biology, collaborations and partnerships within the biopharmaceutical industry, progress in virology and immunology, and an increased focus on pediatric oncology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12391&type=smp

Which Industry Drivers Are Expected To Accelerate The Oncolytic Virus Therapy Market From 2025 To 2029?

The escalating incidence of cancer cases is anticipated to drive the expansion of the oncolytic virus therapy market moving forward. Cancer denotes a spectrum of diseases identified by the uncontrolled multiplication and spread of abnormal cells within the body. Oncolytic virus therapy provides the ability to selectively target and eradicate cancer cells while simultaneously stimulating an immune response against the tumor, thereby offering a dual mechanism for effective cancer treatment. For instance, in January 2023, the American Cancer Society Inc., a US-based non-profit organization, projected 609,820 cancer deaths and 1,958,310 new cancer cases in the US during 2022. Therefore, the increasing prevalence of cancer cases is fueling the growth of the oncolytic virus therapy market.

What Are The Leading Segments Analyzed In The Oncolytic Virus Therapy Market?

The oncolytic virus therapymarket covered in this report is segmented –

1) By Therapy Type: HSV-Based Oncolytic Virus Therapy; Adenovirus-Based Oncolytic Virus Therapy; Reovirus; Poxviruses; NDV (Newcastle Disease Virus); Other Therapy Types

2) By Virus Type: Genetically Engineered Oncolytic Viruses; Oncolytic Wild-Type Viruses

3) By Application: Breast Cancer; Lung Cancer; Prostate Cancer; Melanoma; Brain Tumor; Blood Cancer

4) By End-User: Hospitals; Specialty Clinics; Cancer Research Institutes

Subsegments:

1) By HSV-Based Oncolytic Virus Therapy: Talimogene Laherparepvec (T-VEC); Other HSV-Based Therapies

2) By Adenovirus-Based Oncolytic Virus Therapy: Onyx-015; AdV-5/3-D24; Other Adenovirus-Based Therapies

3) By Reovirus: Reolysin; Other Reovirus Therapies

4) By Poxviruses: JX-594 (OncoVac); Other Poxvirus Therapies

5) By NDV (Newcastle Disease Virus): NDV-Based Therapies; Other NDV Applications

6) By Other Therapy Types: Combination Therapies; Other Emerging Oncolytic Virus Therapies

What Long-Term Trends Will Shape The Future Growth Of The Oncolytic Virus Therapy Industry?

Leading companies operating in the oncolytic virus therapy market are focusing on obtaining regulatory clearances to expedite the introduction of innovative cancer treatments. Regulatory approvals refer to the process by which health authorities evaluate and authorize medical products, including drugs, biologics, and medical devices, for market use. For instance, in March 2024, ImmVira, a China-based biotechnology company, secured Fast Track designation from the FDA for its oncolytic virus therapy, MVR-T3011 IT. This therapy targets recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) in patients whose disease has progressed after platinum-based chemotherapy and at least one prior line of anti-PD-1/PD-L1 therapy. This designation aims to accelerate the development and review process for therapies addressing serious conditions with unmet medical needs.

Which Global Market Leaders Are Shaping The Future Of The Oncolytic Virus Therapy Sector?

Major companies operating in the oncolytic virus therapy market include Pfizer Inc., Johnson & Johnson, Sorrento Therapeutics Inc., AbbVie Inc., AstraZeneca plc, Amgen Inc., Boehringer Ingelheim Group, Regeneron Pharmaceuticals, Daiichi Sankyo Company Limited, Kissei Pharmaceutical Co. Ltd., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Adze Biotechnology, Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Circio Holding ASA, Lokon Pharma AB, Provectus Biopharmaceuticals Inc., Vibalogics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Oncolytic Virus Therapy Market?

North America was the largest region in the oncolytic virus therapy market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic virus therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Oncolytic Virus Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12391&type=smp

Browse Through More Reports Similar to the Global Oncolytic Virus Therapy Market 2025, By The Business Research Company

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Anti Cancer Mabs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-cancer-mabs-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795